Symposium GI-K-01 (UG)
Nov. 15 (Thu) 09:00-10:30	Prevention of gastric cancer	203 (2F)
Chairperson(s)	Sang Young Seol (Busan), Jae J Kim (Seoul)
09:00-09:20	Primary prevention: role of H. pylori eradication	Kee Don Choi (Seoul)
09:20-09:40	Secondary prevention: role of H. pylori eradication after endoscopic resection of gastric epithelial neoplasia	Hiroto Miwa (Nishinomiya)
09:40-10:00	Secondary prevention: role of H. pylori eradication after partial gastrectomy	Da Hyun Jung (Seoul)
10:00-10:20	Chemoprevention of gastric cancer other than H. pylori eradication	Soo-Jeong Cho (Seoul)
10:20-10:30	Q&As

Free Paper (UG 1) (Korean & English)
Nov. 15 (Thu) 09:00-10:30	KDDW Free Paper (UG 01)	E3+4 (3F)
Chairperson(s)	Sung Joon Lee (Chuncheon), Sun-Young Lee (Seoul)
09:00-09:10	Development of LGR5-targeting peptide probe and validation in gastric cancer cells	Jae Myung Park (Seoul)
09:10-09:20	Circular RNA_009414 /miR-30c-2-3p axis promotes gastric cancer via BCL9/Wnt/-catenin signaling pathway	Xuan Li (Nanjing)
09:20-09:30	Dietary and physical activity effect on gastric cancer in multi-center prospective registry	Su Youn Nam (Daegu)
Chairperson(s)	Jin Il Kim (Seoul), Chan Gyoo Kim (Goyang)
09:30-09:40	Application of artificial intelligence (AI) technology for the prediction of invasion depth in early gastric cancer (EGC)	Hong Jin Yoon (Seoul)
09:40-09:50	M1a disease should be reconsidered in esophageal cancer staging system from the perspective of treatment response and survival after definitive concurrent chemoradiotherapy	Tae Ryong Chung (Seoul)

Free Paper (Motility 1) (Korean)
Nov. 15 (Thu) 09:00-10:30	KDDW Free Paper (Motility 01)	E5 (3F)
Chairperson(s)	Young Woo Kang (Daejeon), Hye-Kyung Jung (Seoul)
09:00-09:10	Identification of genetic factors associated with reflux esophagitis using a genome-wide association study in the Korean population	Eun Hyo Jin (Seoul)
09:10-09:20	Gender differences in association between waist circumference and the risk of reflux esophagitis	Hyo-Joon Yang (Seoul)
09:20-09:30	Gastroesophageal reflux disease in subjects with sleep disordered breathing	Min Jae Cho (Seoul)
Chairperson(s)	Sung Pyo Hong (Seongnam), Kyung Sik Park (Daegu)
09:30-09:40	Association between skeletal muscle attenuation and gastroesophageal reflux disease : A health check-up cohort study	Young Min Kim (Seoul)
09:40-09:50	The effect of rebamipide in patients with gastroesophageal reflux disease, including non-erosive reflux disease: a multi-center, randomized, single-blind, placebo-controlled study (RENERD Study)	Soon Man Yoon (Cheongju)
09:50-10:00	Prophylactic anti-reflux surgery after laparoscopic gastric wedge resections for gastric submucosal tumors of gastroesophageal junction	Chang Hyun Kim (Incheon)

Symposium GI-K-02 (Motility)
Nov. 15 (Thu) 11:00-12:30	Dyspepsia: what’s new in 2018? (ANMA-KSNM joint session)	203 (2F)
Chairperson(s)	Hyojin Park (Seoul), Oh Young Lee (Seoul)
11:00-11:20	Epidemiology of functional dyspepsia in Asia	Hyojin Park (Seoul)
11:20-11:40	New pathogenesis of functional dyspepsia	Kwang Jae Lee (Suwon)
11:40-12:00	Helicobacter pylori-associated dyspepsia	Kentaro Sugano (Shimotsuke)
12:00-12:20	Novel treatment of dyspepsia	Justin CY Wu (Hong Kong)
12:20-12:30	Q&As

PG Course-GI Cancer (Korean)
Nov. 15 (Thu) 11:00-12:30	Update and change of health insurance coverage for gastrointestinal cancer in Korea 2018	E1+2 (3F)
Chairperson(s)	Kwang Ro Joo (Seoul), Sung Soo Kim (Uijeongbu)
11:00-11:20	Esophageal/ stomach cancer	Hee Seok Moon (Daejeon)
11:20-11:40	Colorectal cancer	Jae Jun Park (Seoul)
11:40-12:00	Pancreatobiliary cancer	Sang Myung Woo (Goyang)
12:00-12:20	Palliative care for gastrointestinal cancer - pain, anti-emetics, nutrition	Bong Eun Lee (Busan)
12:20-12:30	Q&As

Free Paper (UG 2) (Korean)
Nov. 15 (Thu) 11:00-12:30	KDDW Free Paper (UG 02)	E3+4 (3F)
Chairperson(s)	Ok-Jae Lee (Jinju), Tae Ho Kim (Bucheon)
11:00-11:10	The Utility of Endoscopic submucosal dissection(ESD) with laparoscopic sentinel lymph node dissection(ESN) and endoscopic full-thickness gastric resection with laparoscopic sentinel lymph node dissection in patients beyond the indications of ESD	Junsu Chang (Sungnam)
11:10-11:20	Clinical outcomes of gastric cardia cancer during a recent decade of Korea	Seonhoo Kim (Suwon)
11:20-11:30	The effect of metformin on prognosis in patients with locally advanced gastric cancer associated with type 2 diabetes mellitus.	Ho Seok Seo (Seoul)
Chairperson(s)	Gwang Ho Baik (Chuncheon), Byung-Hoon Min (Seoul)
11:30-11:40	Long-term outcome of Helicobacter pylori-negative and Pepsinogen-positive group D patients of health checkup Koreans	Yoo Min Han (Seoul)
11:40-11:50	Should the triple therapy be thrown away for Helicobacter pylori eradication? ; Efficacy of metronidazole-containing triple therapy after Clarithromycin-contaning triple therapy failure	Chang Min Lee (Jinju)
11:50-12:00	A 7 day triple therapy efficacy is similar with 14-day therapy for the eradication of Helicobacter Pylori with no point mutation in 23S rRNA	Hyeong Jin Kim (Yangsan)
12:00-12:10	Walnut phenolic extract inhibited Helicobacter pylori-induced STAT3 phosphorylation through activation of PPAR-gamma	Jeong-Min An (Seongnam)

PG Course-UG
Nov. 15 (Thu) 14:00-15:30	Overview of recent progress in upper GI diseases	103 (1F)
Chairperson(s)	Jaw-Town Lin (Taipei), Myung-Gyu Choi (Seoul)
14:00-14:20	Diagnosis and treatment of GERD	Sabine Roman (Lyon)
14:20-14:40	Management of peptic ulcer disease	Joseph J Y Sung (Hong Kong)
14:40-15:00	Helicobacter pylori eradication in Asia-Pacific regions	Jaw-Town Lin (Taipei)
15:00-15:20	Effect of screening endoscopy for gastric cancer in regions where Helicobacter pylori is prevalent	Soo-Jeong Cho (Seoul)
15:20-15:30	Q&As

PG Course-Motility (Korean)
Nov. 15 (Thu) 14:00-15:30	A to Z of constipation	E1+2 (3F)
Chairperson(s)	Sei Jin Youn (Cheongju), Joonseong Lee (Seoul)
14:00-14:20	Pathophysiology	Jeong Eun Shin (Cheonan)
14:20-14:40	Assessment	Seong-Eun Kim (Seoul)
14:40-15:00	Pharmacologic treatment	Kee Wook Jung (Seoul)
15:00-15:20	Nonpharmacologic treatment	Tae Hee Lee (Seoul)
15:20-15:30	Q&As

Free Paper (UG 3) (Korean & English)
Nov. 15 (Thu) 14:00-15:30	KDDW Free Paper (UG 03)	E5 (3F)
Chairperson(s)	Jin Tae Jung (Daegu), Cheol Woong Choi (Yangsan)
14:00-14:10	The increasing incidence and identifying biomarkers of eosinophilic esophagitis in Korea	Ga Hee Kim (Seoul)
14:10-14:20	Peroral endoscopic myotomy for the treatment of achalasia: Procedural outcomes in elderly and not elderly patients	Ju Sung Kim (Seongnam)
14:20-14:30	Stomach property with stress and strain depending on location and direction for developing virtual stomach model	Seung Han Kim (Seoul)
14:30-14:40	The expression of H+,K+-ATPase and interleukin-1B according to H. pylori infection and intestinal metaplasia	Hee Jin Kim (Seongnam)
Chairperson(s)	Sok Won Han (Bucheon), Dae Young Cheung (Seoul)
14:40-14:50	High risk factors for upper gastrointestinal malignancy among patients presenting with dysphagia: Analysis of patients who presented a tertiary care center in Sri Lanka	Nadeesha Jeewan Nawarathna (Mawanella)
14:50-15:00	Risk factor for peptic ulcer in Buddhist priests compared to general population : A cross-sectional, case-control study	Sung Hun Choi (Goyang)
15:00-15:10	BST-104, a water extract of lonicera japonica, has a gastroprotective effect through antioxidant and anti-inflammatory actions	Jongbeom Shin (Incheon)
15:10-15:20	DM remission rate after sleeve or bypass; utilizing individualized metabolic surgery (IMS) score for Korean obese patients	Dae Geun Park (Seoul)

PG Course-LG
Nov. 15 (Thu) 16:00-17:30	Recent update in lower GI diseases	103 (1F)
Chairperson(s)	Peter Gibson (Melbourne), Tae Il Kim (Seoul)
16:00-16:20	The cutting edge strategy for the treatment of inflammatory bowel disease therapy	Choon Jin Ooi (Singapore)
16:20-16:40	Quality issues in colonoscopic screening for colorectal cancer	Uri Ladabaum (Redwood)
16:40-17:00	Treatment of IBS: low-FODMAP diet and beyond	Peter Gibson (Melbourne)
17:00-17:20	Upates in diagnosis and treatment for Clostridium difficile infection	You Sun Kim (Seoul)
15:20-15:30	Q&As

Symposium GI-K-03 (LG)
Nov. 15 (Thu) 16:00-17:30	Recent progress on translational research in colorectal neoplasm	203 (2F)
Chairperson(s)	Yoon Tae Jeen (Seoul), Joseph J Y Sung (Hong Kong)
16:00-16:20	Novel biomarkers of noninvasive diagnosis of colorectal cancer: Fecal microbiota	Joseph J Y Sung (Hong Kong)
16:20-16:40	Optimal strategy of colorectal cancer screening in Asia	Han-Mo Chiu (Taipei)
16:40-17:00	Emerging imaging techniques for colorectal neoplasm	Seung-Jae Myung (Seoul)
17:00-17:20	New targeting agents for treatment of colorectal neoplasm	Jae Hyun Kim (Busan)
15:20-15:30	Q&As

PG Course-UG (Korean)
Nov. 15 (Thu) 16:00-17:30	Unmet needs in upper gastrointestinal diseases	E1+2 (3F)
Chairperson(s)	Jong Sun Rew (Gwangju), Jong-Jae Park (Seoul)
16:00-16:20	소화성궤양 합병증: 어떻게 대처할 것인가?	Ju Yup Lee (Daegu)
16:20-16:40	조기위암의 내시경적 절제술: 그 다음 이야기	Wan-Sik Lee (Gwangju)
16:40-17:00	불응성 역류성 식도염: 무엇을 더 해야 하나?	Moo-In Park (Busan)
17:00-17:20	위축성위염, 장상피화생, 그리고 이형성: 단계별 추적검사	Woo Chul Chung (Suwon)
15:20-15:30	Q&As

Free Paper (Motility 2) (Korean)
Nov. 15 (Thu) 16:00-17:30	KDDW Free Paper (Motility 02)	E5 (3F)
Chairperson(s)	Joong Goo Kwon (Daegu), Yong Sung Kim (Iksan)
16:00-16:10	Endoflip(Endolumenal Functional Lumen Imaging Probe) in diagnosis of gastroesophageal reflux disease	Eunju Kim (Seongnam)
16:10-16:20	pH impedance and high resolution esophageal manometry in symptomatic patients with cervical inlet patch	Tae Hee Lee (Seoul)
16:20-16:30	Relationship between gender roles and psychiatric factors in patients with irritable bowel syndrome	Jung Hwan Oh (Seoul)
Chairperson(s)	Chong-Il Sohn (Seoul), Jung Hwan Oh (Seoul)
16:30-16:40	A newly developed minimally invasive wireless gastrostimulator : A pilot study	Sang Hoon Kim (Seoul)
16:40-16:50	Clinical characteristics of achalasia with normal IRP and outcomes after POEM	Eunju Kim (Seongnam)
16:50-17:00	Epidemiology and incidence of achalasia in korea based on nationwide big data: From conventional to high-resolution manometry era	Ga Hee Kim (Seoul)

Symposium GI-01 (Motility)
Nov. 16 (Fri) 08:30-10:00	Updates in gastrointestinal neurogastro-motility disorders	105 (1F)
Chairperson(s)	Nicholas J Talley (Newcastle), Kwang Jae Lee (Suwon)
08:30-08:50	Approach to esophageal disorders	John Pandolfino (Wilmette)
08:50-09:10	Approach to gastric disorders	Nicholas J Talley (Newcastle)
09:10-09:30	Approach to bowel disorders	Eamonn Quigley (Houston)
09:30-09:50	Differences of guidelines between Asia and West	Jung-Ho Park (Seoul)
09:50-10:00	Q&As

Free Paper (GI Cancer 1) (Korean)
Nov. 16 (Fri) 08:30-10:00	KDDW Free Paper (GI Cancer 01)	E4 (3F)
Chairperson(s)	Jin Tae Jung (Daegu), Su Youn Nam (Daegu)
08:30-08:40	Effects of a 12 week home-based exercise program in patients with high risk of gastric cancer: A pilot study	Jeung Eun Lee (Seoul)
08:40-08:50	Subepithelial spread of early gastric signet ring cell carcinoma: How far they can reach?	Sun Hyung Kang (Daejeon)
08:50-09:00	Gastric cancer with lymph node metastasis more than 15 (N3b): is it really stage III disease?	Sa-Hong Kim (Seoul)
09:00-09:10	Predictive factors of lymph node metastasis in early gastric cancer patients with Seiwert type II/III	Min Young Son (Busan)
09:10-09:20	Abdominal computed tomography compared with endoscopic ultrasound sonography for the diagnosis of gastric subepithelial tumors	Cheal Wung Huh (Incheon)
Chairperson(s)	Eun Kwang Choi (Jeju), Seung-Ok Lee (Jeonju)
09:30-09:40	Incidence and prognosis of subsequent cholangiocarcinoma in patients with hepatic resection for bile duct stones	Seon Mee Park (Cheongju)
09:40-09:50	Validation of the 8th edition of the American Joint Commission on Cancer (AJCC) staging system for pancreatic adenocarcinoma: Using Korean pancreatic cancer (K-PAC) registry	Dong Woo Shin (Seongnam)
09:50-10:00	Clinicopathologic characteristics of Intraductal Papillary Neoplasm of Bile duct (IPNB) after central review: Korean multi-center collaboration study	Jae Ri Kim (Seoul)
10:00-10:10	Adjuvant gemcitabine-based chemotherapy vs concurrent chemoradiotherapy after R0 resection for pancreatic ductal adenocarcinoma: A propensity score-matched analysis	Min Su You (Seoul)

Free Paper (LG 1) (Korean)
Nov. 16 (Fri) 08:30-10:00	KDDW Free Paper (LG 01)	E5 (3F)
Chairperson(s)	Kyu Chan Huh (Daejeon), Sung-Ae Jung (Seoul)
08:30-08:40	A trial for the administration of a functionally enhanced tonsil-derived mesenchymal stem cells in a chronic colitis model.	Yang Hee Joo (Seoul)
08:40-08:50	The ability of epithelial regeneration is reduced in the Crohn's disease patient-derived organoids, especially in TNF-alpha enriched condition.	Sung Noh Hong (Seoul)
08:50-09:00	Diagnostic role of NOD signaling and apoptosis tests in patients with XIAP-deficient IBD	Seak Hee Oh (Seoul)
09:00-09:10	Mutation analysis of adenomas and carcinomas of the colon: Early and late drivers	Soo-Kyung Park (Seoul)
09:10-09:20	Identification of prominent hub genes of colorectal cancer : Using network analysis of gene expression data	Seong Ji Choi (Seoul)
Chairperson(s)	Byong Duk Ye (Seoul), Geom Seog Seo (Iksan)
09:20-09:30	Vegetarianism as a protective factor for asymptomatic colonic diverticulosis; A cross-sectional, case-control study between Buddhist priests and general population	Jihun Bong (Goyang)
09:30-09:40	Clinical outcome after endoscopic decompression of sigmoid volvulus; A multicenter-retrospective study, Daejeon-Chungchung intestinal research group	Hee Seok Moon (Daejeon)
09:40-09:50	Identification and validation of a peptide probe binding specifically to colon cancer cells	Younghee Choe (Seoul)

Free Paper (LG 2) (Korean & English)
Nov. 16 (Fri) 10:20-11:10	KDDW Free Paper (LG 02)	E5 (3F)
Chairperson(s)	Jin-Oh Kim (Seoul), Chang Hwan Choi (Seoul)
10:20-10:30	Association of time to colonoscopy after a positive fecal test result and fecal hemoglobin	Kyung Mo Yoo (Seoul)
10:30-10:40	Clinicopathological features of malignant tumors of small bowel diagnosed by video capsule endoscopy and balloon-assisted enteroscopy: A single center experience	Sunghee Kam (Seoul)
10:40-10:50	Modifiable lifestyle risk factors and the risk of colorectal neoplasia recurrence	Kyungjin Ko (Seoul)
10:50-11:00	Differences in the clinicopathologic characteristics between right- and left-sided colon cancer	Hannah Ra (Incheon)
11:00-11:10	Epidemiology of colorectal cancer in Northern Malaysia: A 7-year review (2008-2014)	Mohamad Fadli Abd Rahman (Alor Setar)

Free Paper (GI Cancer 2) (Korean & English)
Nov. 16 (Fri) 10:30-12:00	KDDW Free Paper (GI Cancer 02)	E4 (3F)
Chairperson(s)	Yun Jeong Lim (Goyang), Bora Keum (Seoul)
10:30-10:40	Changing trends of colonoscopic burden: A nationwide population-based study in Korea	Jae Myung Cha (Seoul)
10:40-10:50	Risk of developing colorectal cancer based on the prior screening behaviors: Population-based cohort study.	Su Young Kim (Wonju)
10:50-11:00	Colorectal cancer screening among cancer survivors in the US	Adeyinka O Laiyemo (Washington)
11:00-11:10	Metabolically healthy obesity is associated with an increased risk of colorectal neoplasia recurrence	Hyun Beom Chae (Seoul)
11:10-11:20	Association between low relative muscle mass and the risk of colorectal neoplasia recurrence in Korean men and women	Kyung Mo Yoo (Seoul)
Chairperson(s)	Jin-Hyeok Hwang (Seongnam), Jae Hee Cho (Incheon)
11:20-11:30	Neoadjuvant FOLFIRINOX in patients with locally advanced pancreatic cancer	Young Hoon Choi (Seoul)
11:30-11:40	Lymphocyte-to-monocyte ratio is a valuable marker for predicting survival in patients with gallbladder cancer undergoing chemotherapy compared to neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio	Young Hoon Choi (Seoul)
11:40-11:50	Clinicopathologic characteristics and kras molecular alterations of adenosquamous carcinoma of the pancreas compared to pancreatic ductal adenocarcinoma	Sun Mi Lee (Jeju)
11:50-12:00	Detection of circulating tumor DNA and its application in pancreatic cancer patients	Joo Kyung Park (Seoul)

Topic Forum (LG) (Korean)
Nov. 16 (Fri) 11:10-12:00	Topic Forum (LG)	E5 (3F)
Chairperson(s)	Hiun Suk Chae (Uijeongbu), Young-Eun Joo (Gwangju)
11:10-11:20	Risk factors including fecal markers for hospitalization in patients with ulcerative colitis	Byung Jin Kwon (Yangsan)
11:20-11:30	Mucosal healing is associated with transmural healing after 1-year treatment with anti-TNF agents in pediatric Crohn's disease patients	Ben Kang (Daegu)
11:30-11:40	Trough levels of adalimumab better correlate with combined mucosal and transmural healing than clinical remission in Korean patients with Crohn's disease on adalimumab maintenance therapy	Eun Hye Oh (Seoul)
11:40-12:00	Keynote Lecuture: Evolving monitoring for IBD patient care in clinical practice	Byung Ik Jang (Daegu)

Symposium GI-02 (UG)
Nov. 16 (Fri) 14:00-15:30	Gastric carcinogenesis: Host, microbiome, and their interactions	101 (1F)
Chairperson(s)	Kwong Ming Fock (Singapore), Ki Baik Hahm (Seongnam)
14:00-14:20	Identification of genetic susceptibility for gastric cancer through genome-wide association studies	Benjamin Wong (Hong Kong)
14:20-14:40	Non-coding RNA and gastric cancer	Sang Kil Lee (Seoul)
14:40-15:00	Interactions between human and Helicobacter pylori in gastric carcinogenesis	Richard Peek (Nashville)
15:00-15:20	Non-Helicobacter pylori microbiome in gastric carcinogenesis	Yoshio Yamaoka (Yufu)
15:20-15:30	Q&As

Symposium GI-03 (LG)
Nov. 16 (Fri) 14:00-15:30	Shifting paradigm in IBD management	202 (2F)
Chairperson(s)	Joo Sung Kim (Seoul), Siew Chien Ng (Hong Kong)
14:00-14:20	New drugs on the horizon: Targeting cytokines, cell trafficking, and more	Choon Jin Ooi (Singapore)
14:20-14:40	Fecal microbiota transplantation for IBD: Ready to use?	Siew Chien Ng (Hong Kong)
14:40-15:00	Toward improving quality of care in IBD management	David Todd Rubin (Chicago)
15:00-15:20	Things you should know when managing elderly IBD patients	Jae Hee Cheon (Seoul)
15:20-15:30	Q&As

Symposium GI-04 (GI Cancer)
Nov. 16 (Fri) 14:00-15:30	Gastirc cancer, are we in new era for management?	E1+2 (3F)
Chairperson(s)	Hyunyong Jeong (Daejeon), James R. Goldenring (Nashville)
14:00-14:20	The global change in epidemiology of gastric cancer	Jin Young Park (Lyon)
14:20-14:40	Role of?SPEM in gastric carcinogenesis	James R. Goldenring (Nashville)
14:40-15:00	Do we have proper surgical modalities to preserve functional aspect after gastric cancer surgery?	Keun Won Ryu (Goyang)
15:00-15:20	Current treatment landscape and future perspectives in patients with advanced gastric cancer	Sung Eun Kim (Busan)
15:20-15:30	Q&As

KDDW Free Paper (LG 3) (Korean)
Nov. 16 (Fri) 14:00-15:30	KDDW Free Paper (LG 3)	E5 (3F)
Chairperson(s)	Kooklae Lee (Seoul), Soon Man Yoon (Cheongju)
14:00-14:10	Cost drivers for inflammatory bowel disease care: a population-based study using the korean national health insurance claims data (2006-2015)	Jung-Wook Kim (Seoul)
14:10-14:20	Real life effectiveness and safety of vedolizumab as induction therapy for Korean IBD patients in whom anti-TNF treatment failed: A prospective cohort study	Jeongseok Kim (Seoul)
14:20-14:30	Influence of Vitamin D status on the clinical course of ulcerative colitis	Nam Seok Ham (Seoul)
Chairperson(s)	Moon Sung Lee (Bucheon), Bo-In Lee (Seoul)
14:30-14:40	Impact of family history of colorectal cancer on age-specific prevalence of colorectal	Seulki Kim (Seoul)
14:40-14:50	The association of cigarette smoking and alcohol consumption with sessile serrated adenoma in 30-49 year-old subjects	Ji Young Lee (Seoul)
14:50-15:00	prevalence of and risk factors for colorectal neoplasia in asymptomatic young adults aged 20 to 39 years	Jin Ju Song (Seoul)
15:00-15:10	Does colon diverticulosis raise the risk of adenomatous colon polyp in patients with colorectal cancer?	Suyun Oh (Suwon)

Symposium GI-05 (LG)
Nov. 16 (Fri) 16:00-17:30	The cutting edge issues in management of IBD 2018	102 (1F)
Chairperson(s)	Suk-Kyun Yang (Seoul), Jiaming Qian (Beijing)
16:00-16:20	What should be the therapeutic targets in IBD therapy?	Siew Chien Ng (Hong Kong)
16:20-16:40	Proper positioning of various drugs in therapeutic algorithm	Won Moon (Busan)
16:40-17:00	Place of TDM in optimal use of biologics	Akira Andoh (Otsu)
17:00-17:20	Managing Crohn's disease after surgery	Kang-Moon Lee (Suwon)
17:20-17:30	Q&As

Symposium GI-06 (UG)
Nov. 16 (Fri) 16:00-17:30	All about GIST on UGI tract	202 (2F)
Chairperson(s)	Chang-Hun Yang (Gyeongju), Byung-Wook Kim (Incheon)
16:00-16:20	Pathologic diagnosis; focused on prognostic factor	Gu Hyun Kang (Seoul)
16:20-16:40	Endoscopic treatment: when and how?	Hanglak Lee (Seoul)
16:40-17:00	Surgical treatment: when and how?	Hyundong Chae (Daegu)
17:00-17:20	Target therapy: when and how?	Dong-Hoe Koo (Seoul)
17:20-17:30	Q&As

PG Course-LG (Korean)
Nov. 16 (Fri) 16:00-17:30	Current status and future perspectives in management of small bowel diseases	E1+2 (3F)
Chairperson(s)	Hyun Soo Kim (Gwangju), Sung-Ae Jung (Seoul)
16:00-16:20	Optimal approach to small bowel bleeding	Hyun Jung Lee (Seoul)
16:20-16:40	Radiologic diagnosis of small bowel diseases	Jeong Kyong Lee (Seoul)
16:40-17:00	Therapeutic role of enteroscopy	Sung Noh Hong (Seoul)
17:00-17:20	Interesting cases of various small bowel diseases	Bong Min Ko (Bucheon)
17:20-17:30	Q&As

Symposium GI-07 (LG)
Nov. 17 (Sat) 08:30-10:00	Updates on the management of gastrointestinal bleeding	103 (1F)
Chairperson(s)	Toshiyuki Matsui (Chikushino), Michael Ka Wah Li (Hong Kong)
08:30-08:50	Treatment of peptic ulcer bleeding: present and future	Yunsheng Yang (Beijing)
08:50-09:10	Diagnostic approach for obscure gastrointestinal bleeding	Ki-Nam Shim (Seoul)
09:10-09:30	Endoscopic management of colonic diverticular bleeding	Hiroshi Kashida (Osaka)
09:30-09:50	Treatment and prevention of Variceal bleeding	Shiv Kumar Sarin (New Delhi)
09:50-10:00	Q&As

Symposium GI-08(UG)
Nov. 17 (Sat) 10:30-12:00	GERD: new diagnostic approach and management in 2018	103 (1F)
Chairperson(s)	Sabine Roman (Lyon), Young-Tae Bak (Seoul)
10:30-10:50	Pathophysiology of GERD: what’s new in 2018?	John Pandolfino (Wilmette)
10:50-11:10	Novel diagnostic approach of GERD: From Ascona to Lyon consensus	Sabine Roman (Lyon)
11:10-11:30	The risk and benefits of long-term use of PPIs	Poong-Lyul Rhee (Seoul)
11:30-11:50	Potassium-competitive acid blockers (P-CAB): Advanced therapeutic option for GERD	George Sachs (Los Angeles)
11:50-12:00	Q&As

Symposium GI-09 (LG)
Nov. 17 (Sat) 14:00-15:30	What are the special issues of IBD in Asians?	102 (1F)
Chairperson(s)	Mamoru Watanabe (Tokyo), Hyo Jong Kim (Seoul)
14:00-14:20	Pathophysiologic mechanisms: Genetics and serology in Asian IBD patients	Byong Duk Ye (Seoul)
14:20-14:40	Differential diagnosis of IBD and IBD mimics in Asia	Shu Chen Wei (Taipei)
14:40-15:00	Prognostication of Asian IBD patients: Different from Westerns?	Zhihua Ran (Shanghai)
15:00-15:20	Therapueutic algorithm in Asia vs. Western: Similarities and differences	Katsuyoshi Matsuoka (Sakura)
15:20-15:30	Q&As

Symposium GI-10 (GI Cancer)
Nov. 17 (Sat) 14:00-15:30	Emerging armamentarium for the management of GI cancer	203 (2F)
Chairperson(s)	Myunghwan Noh (Busan), Seun Ja Park (Busan)
14:00-14:20	Liquid biopsies: technology overview and clinical implications	Dong Uk Kim (Busan)
14:20-14:40	Revisiting an old weapon: HIPEC for GI cancer	Seung Hyuk Baik (Seoul)
14:40-15:00	Immune therapy: Is this ready for use in GI cancer?	Yusuke Hashimoto (Kashiwa)
15:00-15:20	Proton beam therapy or Particle beam therapy	Tae Hyun Kim (Goyang)
15:20-15:30	Q&As

Symposium GI-11 (UG)
Nov. 17 (Sat) 16:00-17:30	What clinicians need to know in ROME IV?	101 (1F)
Chairperson(s)	Kentaro Sugano (Shimotsuke), Justin CY Wu (Hong Kong)
16:00-16:20	Introduction and overview	Nicholas J Talley (Newcastle)
16:20-16:40	Esophageal disorders	Hiroto Miwa (Nishinomiya)
16:40-17:00	Gastroduodenal disorders	Nicholas J Talley (Newcastle)
17:00-17:20	Bowel disorders	Suck Chei Choi (Iksan)
17:20-17:30	Q&As

Symposium GI-12 (LG)
Nov. 17 (Sat) 16:00-17:30	Emerging issues in colorectal cancer screening in Asian-Pacific region	102 (1F)
Chairperson(s)	Khean Lee Goh (Kuala Lumpur), Uri Ladabaum (Redwood)
16:00-16:20	Early-onset colorectal cacner in Asia-Pacific	Hyun-Soo Kim (Wonju)
16:20-16:40	Recent updates in biological markers in colorectal cancer screening	Joseph J Y Sung (Hong Kong)
16:40-17:00	Obstacles and inequities in colorectal cancer screening in Asian-Pacific regions	Han-Mo Chiu (Taipei)
17:00-17:20	Cost-effectiveness of colorectal cancer screening	Hermann Brenner (Heidelberg)
17:20-17:30	Q&As

Symposium GI-13 (UG)
Nov. 18 (Sun) 10:30-12:00	Recent issues in diagnostic and therapeutic endoscopy	101 (1F)
Chairperson(s)	Hoon Jai Chun (Seoul), Kenshi Yao (Chikushino)
10:30-10:50	E-learning system for increasing diagnostic performance in early gastric cancer	Kenshi Yao (Chikushino)
10:50-11:10	Robot-assisted endoscopic resection	Khek Yu Ho (Singapore)
11:10-11:30	Quality of ESD: It's time to look back	Seiichiro Abe (Tokyo)
11:30-11:50	Satety of endoscopic treatment for GISTs	Jong-Jae Park (Seoul)
11:50-12:00	Q&As

Symposium GI-14 (UG)
Nov. 18 (Sun) 10:30-12:00	Current understanding of peptic ulcer disease	103 (1F)
Chairperson(s)	Jaw-Town Lin (Taipei), Yong Chan Lee (Seoul), Ian Roberts-Thomson (Hawthorn)
10:30-10:50	Pathophysiology and treatment of peptic ulcer	Varocha Mahachai (Bangkok)
10:50-11:10	Helicobacter-negative peptic ulcer: the prevention and treatment	Khien Van Vu (Hanoi)
11:10-11:30	GI bleeding in the era of direct oral anticoagulants	Akiko Shiotani (Kurashiki)
11:30-11:50	Endoscopic management of peptic ulcer bleeding: recent update	Sunny Wong (Hong Kong)
11:50-12:00	Q&As

Symposium GI-15 (LG)
Nov. 18 (Sun) 13:30-15:00	IBS: update 2018	103 (1F)
Chairperson(s)	Minhu Chen (Guangzhou), Oh Young Lee (Seoul)
13:30-13:50	Low FODMAP diet: what we know in 2018	Peter Gibson (Melbourne)
13:50-14:10	Post-infectious IBS: its mechanism and clinical course	Hyojin Park (Seoul)
14:10-14:30	Psychosomatic approach for IBS	Shin Fukudo (Sendai)
14:30-14:50	Microbiota in IBS: friend or foe?	Eamonn Quigley (Houston)
14:50-15:00	Q&As